Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.
Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, Spyridopoulos T, Chatziioannou A, Sotirchos V, Karampelas T, Tamvakopoulos C, Filippiadis D, Karagiannis E, Marinis A, Koskinas J, Kelekis DA. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2014 Feb;37(1):165-75. doi: 10.1007/s00270-013-0777-x. Epub 2013 Nov 22. Cardiovasc Intervent Radiol. 2014. PMID: 24263774 Free PMC article.
Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.
Malagari K, Pomoni M, Spyridopoulos TN, Moschouris H, Kelekis A, Dourakis S, Alexopoulou E, Koskinas J, Angelopoulos M, Kornezos J, Pomoni A, Tandeles S, Marinis A, Rizos S, Kelekis D. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2011 Aug;34(4):774-85. doi: 10.1007/s00270-010-0044-3. Epub 2010 Dec 24. Cardiovasc Intervent Radiol. 2011. PMID: 21184228
Post embolization syndrome in doxorubicin eluting chemoembolization with DC bead.
Pomoni M, Malagari K, Moschouris H, Spyridopoulos TN, Dourakis S, Kornezos J, Kelekis A, Thanos L, Chatziioanou A, Hatjimarkou I, Marinis A, Koskinas J, Kelekis D. Pomoni M, et al. Among authors: koskinas j. Hepatogastroenterology. 2012 May;59(115):820-5. doi: 10.5754/hge11347. Hepatogastroenterology. 2012. PMID: 22024228
Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.
Malagari K, Pomoni M, Moschouris H, Bouma E, Koskinas J, Stefaniotou A, Marinis A, Kelekis A, Alexopoulou E, Chatziioannou A, Chatzimichael K, Dourakis S, Kelekis N, Rizos S, Kelekis D. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2012 Oct;35(5):1119-28. doi: 10.1007/s00270-012-0394-0. Epub 2012 May 22. Cardiovasc Intervent Radiol. 2012. PMID: 22614031 Clinical Trial.
Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.
Malagari K, Kiakidis T, Pomoni M, Moschouris H, Emmanouil E, Spiridopoulos T, Sotirchos V, Tandeles S, Koundouras D, Kelekis A, Filippiadis D, Charokopakis A, Bouma E, Chatziioannou A, Dourakis S, Koskinas J, Karampelas T, Tamvakopoulos K, Kelekis N, Kelekis D. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2016 Oct;39(10):1379-91. doi: 10.1007/s00270-016-1382-6. Epub 2016 Jul 8. Cardiovasc Intervent Radiol. 2016. PMID: 27393274
Erratum to: Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.
Malagari K, Kiakidis T, Pomoni M, Moschouris H, Emmanouil E, Spiridopoulos T, Sotirchos V, Tandeles S, Koundouras D, Kelekis A, Filippiadis D, Charokopakis A, Bouma E, Chatziioannou A, Dourakis S, Koskinas J, Karampelas T, Tamvakopoulos K, Kelekis N, Kelekis D. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2016 Oct;39(10):1537. doi: 10.1007/s00270-016-1424-0. Cardiovasc Intervent Radiol. 2016. PMID: 27468837 No abstract available.
Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30-60 μm: Results from a Single-Centre Prospective Phase II Trial.
Malagari K, Moschouris H, Kiakidis T, Harward S, Kelekis A, Vrakas S, Koundouras D, Filipiadis D, Glantzounis G, Emmanouil E, Chatziioannou A, Vergadis V, Elefsiniotis I, Koskinas J, Dourakis S, Kelekis N. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2019 Nov;42(11):1551-1562. doi: 10.1007/s00270-019-02260-3. Epub 2019 Jul 18. Cardiovasc Intervent Radiol. 2019. PMID: 31321482 Clinical Trial.
143 results